
Canada · Medical startup
RS Therapeutics offers advanced compounding propellant-free foam, which is designed for topical delivery of diclofenac sodium.
Listed
Add your raise, your deck and your story, and put RS Therapeutics in front of investors. Or tell us what we have wrong.